GO:0060010 Sertoli cell fate commitment: Developmental Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060010 Sertoli cell fate commitment is the biological process by which a bipotential gonadal somatic cell acquires and fixes the Sertoli cell identity.
• The process is initiated by transient expression of SRY in XY gonadal somatic cells, followed by sustained SOX9 expression that locks in the Sertoli fate.
• Key transcription factors include SRY, SOX9, GATA4, WT1, NR5A1 (SF1), DMRT1, and AMH, which together establish and maintain Sertoli cell identity.
• Chromatin remodeling and epigenetic changes are essential for stabilizing Sertoli cell fate commitment.
• Disruption of Sertoli cell fate commitment leads to disorders of sex development (DSD), gonadal dysgenesis, and infertility.
• Single-cell and single-nucleus multi-omics have revealed conserved and species-specific features of Sertoli cell fate commitment across mammals and birds.
Description
Sertoli cell fate commitment (GO:0060010) is a fundamental developmental process in which bipotential gonadal somatic cells acquire and stabilize the Sertoli cell identity. This process is critical for testis determination and subsequent male reproductive function, as Sertoli cells serve as the primary organizers of the testis cord and support germ cell development. Understanding the molecular mechanisms that drive Sertoli cell fate commitment is essential for elucidating disorders of sex development (DSD), gonadal dysgenesis, and male infertility. Recent advances in single-cell transcriptomics and chromatin accessibility profiling have provided unprecedented insights into the transcriptional and epigenetic landscapes that govern this fate decision. This article synthesizes current knowledge on the definition, mechanisms, key genes, and research methods relevant to GO:0060010, with a focus on evidence from authoritative QuickGO annotations and published literature.
Sertoli cell fate commitment At A Glance
| GO ID | GO:0060010 |
|---|---|
| GO term | Sertoli cell fate commitment |
| Ontology | biological_process |
| Synonym | None |
| Major function | Acquisition and determination of Sertoli cell identity from bipotential gonadal somatic cells |
| Key regulators | SRY, SOX9, GATA4, WT1, NR5A1, DMRT1, AMH |
| Associated processes | Sex determination, testis cord formation, gonadal development |
| Disease relevance | Disorders of sex development (DSD), gonadal dysgenesis, infertility |
| Research methods | Single-cell RNA-seq, ATAC-seq, CRISPR screens, lineage tracing |
What Is GO:0060010?
According to the Gene Ontology, GO:0060010 (Sertoli cell fate commitment) is defined as the process in which the cellular identity of Sertoli cells is acquired and determined. This encompasses the initial specification of bipotential gonadal somatic cells toward the Sertoli lineage and the subsequent stabilization of that fate, ensuring that these cells commit to a Sertoli cell identity rather than an alternative (e.g., granulosa cell) fate.
Why Is Sertoli cell fate commitment Important in Cell Biology?
Sertoli cell fate commitment is a pivotal event in mammalian sex determination and testis development. It ensures the proper formation of testis cords and the establishment of the male reproductive system. Defects in this process can lead to severe clinical conditions such as 46,XY DSD, gonadal dysgenesis, and infertility. Moreover, understanding the molecular underpinnings of Sertoli cell fate commitment provides insights into general principles of cell fate specification, epigenetic regulation, and organogenesis. Research on this process also informs reproductive toxicology, as environmental exposures can disrupt fetal testis development and Sertoli cell function.
• Essential for testis determination and male reproductive development.
• Disruption causes disorders of sex development (DSD) and gonadal dysgenesis.
• Sertoli cells support spermatogenesis; their fate commitment is prerequisite for male fertility.
• Provides a paradigm for understanding cell fate commitment and epigenetic stabilization.
• Involved in species-specific sex determination mechanisms (e.g., birds).
• Target of environmental endocrine disruptors such as phthalates.
• Key to regenerative strategies for infertility and gonadal tissue engineering.
• Reveals conserved and divergent features of gonadal development across vertebrates.
• Informs diagnosis and potential therapies for DSD patients.
• Offers insights into chromatin remodeling in cell fate decisions.
What Happens During Sertoli cell fate commitment?
Initiation by SRY Expression
In simple terms: The process starts when a gene called SRY turns on in the gonadal cells.
In XY gonads, transient expression of the Y-linked gene SRY in bipotential somatic cells initiates Sertoli cell fate commitment. SRY acts as a transcriptional trigger that upregulates SOX9, a master regulator of Sertoli cell differentiation. This step is tightly regulated and represents the primary switch from bipotential to testis-determining fate.
SOX9 Activation and Maintenance
In simple terms: SOX9 is the main gene that locks in the Sertoli cell identity.
Following SRY induction, SOX9 expression becomes upregulated and is maintained through auto-regulatory loops and positive feedback involving FGF9 and prostaglandin D2. SOX9 is essential for Sertoli cell fate commitment and testis cord formation; its sustained expression is a hallmark of committed Sertoli cells. Loss of SOX9 results in ovarian development in XY individuals.
Transcriptional Network and Chromatin Remodeling
In simple terms: Many other proteins work together and change how DNA is packaged to stabilize the new cell identity.
A network of transcription factors including GATA4, WT1, NR5A1 (SF1), and DMRT1 cooperates with SOX9 to establish the Sertoli cell transcriptional program. Chromatin accessibility changes, such as those mediated by histone modifications and DNA methylation, are critical for stabilizing Sertoli cell fate commitment. Single-cell ATAC-seq studies have revealed dynamic chromatin landscapes during this process.
Morphological and Functional Differentiation
In simple terms: The cells start to look and act like Sertoli cells, forming testis cords.
Committed Sertoli cells undergo morphological changes, including polarization and formation of tight junctions, and begin to express Sertoli-specific markers such as AMH and SOX9. They organize into testis cords, which are essential for subsequent germ cell development and spermatogenesis. This step marks the completion of fate commitment and the beginning of functional maturation.
Key Genes Involved in GO:0060010 Sertoli cell fate commitment
The following genes are central to Sertoli cell fate commitment, as evidenced by genetic and molecular studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SRY | Initiation of Sertoli cell fate commitment | Y-linked trigger; mutations cause 46,XY DSD |
| SOX9 | Master regulator; maintenance of Sertoli identity | Haploinsufficiency causes campomelic dysplasia with DSD |
| GATA4 | Co-activator of Sertoli cell genes | Mutations associated with DSD |
| WT1 | Transcription factor; gonadal development | Mutations cause Wilms tumor and DSD |
| NR5A1 (SF1) | Steroidogenic factor; Sertoli cell differentiation | Mutations linked to DSD and adrenal insufficiency |
| DMRT1 | Maintenance of Sertoli cell fate | Deletions associated with DSD and testicular cancer |
| AMH | Sertoli cell marker; Müllerian duct regression | Used as marker for Sertoli cell commitment |
| FGF9 | Signaling factor; SOX9 maintenance | Critical for testis cord formation |
| PTGDS | Prostaglandin D2 synthase; SOX9 stabilization | Involved in Sertoli cell fate maintenance |
| SOX8 | Redundant with SOX9 in Sertoli cells | Compensates for SOX9 loss in some contexts |
| CBX2 | Chromatin modifier; gonadal development | Mutations cause DSD |
| MAP3K1 | Signaling kinase; testis determination | Variants associated with DSD |
| NR0B1 (DAX1) | Antagonist of Sertoli cell fate | Duplication causes DSD |
| WNT4 | Promotes ovarian fate; antagonizes Sertoli fate | Overexpression causes DSD |
| RSPO1 | Wnt signaling; ovarian fate | Mutations cause DSD |
| FOXL2 | Granulosa cell fate; antagonizes Sertoli fate | Mutations cause BPES and DSD |
| CTNNB1 | Wnt signaling; ovarian fate | Involved in antagonizing Sertoli fate |
How Is Sertoli cell fate commitment Regulated?
Sertoli cell fate commitment is regulated by a complex interplay of transcription factors, signaling pathways, and epigenetic modifiers. Key regulatory loops include the SRY-SOX9-FGF9 positive feedback loop that reinforces SOX9 expression. Antagonistic signals from ovarian-promoting factors such as WNT4, RSPO1, and FOXL2 must be suppressed for Sertoli fate to proceed. Chromatin remodeling complexes, including SWI/SNF, modulate accessibility of Sertoli-specific enhancers. Additionally, environmental factors such as endocrine-disrupting chemicals (e.g., phthalates) can disrupt this process by interfering with hormone signaling and gene expression.
Sertoli cell fate commitment and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SRY | 46,XY DSD (Swyer syndrome) | Sry knockout mouse; CRISPR point mutation in human cells |
| SOX9 | Campomelic dysplasia with DSD | Sox9 conditional knockout mouse; knock-in of patient mutations |
| NR5A1 | 46,XY DSD with adrenal insufficiency | Nr5a1 knockout mouse; CRISPR knock-in of variants |
| WT1 | Wilms tumor, DSD | Wt1 knockout mouse; patient-derived iPSCs |
| DMRT1 | Testicular cancer, DSD | Dmrt1 knockout mouse; CRISPR knockout in cell lines |
Disorders of Sex Development (DSD)
Disorders of sex development (DSD) often arise from mutations in genes controlling Sertoli cell fate commitment. For example, mutations in SRY, SOX9, NR5A1, and WT1 can cause 46,XY DSD with gonadal dysgenesis. These conditions underscore the critical role of proper Sertoli cell fate commitment in human sexual development. Clinical presentations include ambiguous genitalia, streak gonads, and infertility.
Gonadal Dysgenesis and Infertility
Failure of Sertoli cell fate commitment leads to gonadal dysgenesis, characterized by fibrous streak gonads and loss of germ cells. This results in infertility and increased risk of gonadal tumors. Animal models with targeted deletions of Sry or Sox9 recapitulate these phenotypes, providing insights into disease mechanisms.
Testicular Cancer
Defects in Sertoli cell differentiation are associated with testicular germ cell tumors, including seminomas. DMRT1 mutations, which impair Sertoli cell fate maintenance, have been linked to testicular cancer predisposition. Understanding the molecular basis of Sertoli cell fate commitment may inform cancer risk assessment and therapies.
Reproductive Toxicology
Environmental exposures to phthalates and other endocrine-disrupting chemicals can disrupt fetal Sertoli cell development, leading to testicular dysgenesis syndrome. Studying Sertoli cell fate commitment helps identify toxicant targets and develop protective strategies.
From Sertoli cell fate commitment-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X initiate Sertoli cell fate? | Knockout of gene X in XY gonadal somatic cells (e.g., CRISPR-Cas9) |
| Does a patient variant impair Sertoli cell commitment? | Point mutation knock-in using CRISPR in cell lines or organoids |
| Can a candidate enhancer drive Sertoli-specific expression? | Knock-in of reporter (e.g., GFP) under candidate enhancer |
| Does overexpression of gene Y promote Sertoli fate? | Overexpression via lentiviral or CRISPR activation |
| What is the role of a chromatin modifier? | Conditional knockout or tagged knock-in for ChIP-seq |
| Can we rescue Sertoli fate in a DSD model? | Knock-in of wild-type gene or CRISPR activation |
How to Study the Sertoli cell fate commitment Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Gene expression at single-cell level | Identify Sertoli cell populations and trajectories |
| snATAC-seq | Chromatin accessibility | Map regulatory elements during commitment |
| CRISPR knockout screen | Gene function loss | Discover essential genes for Sertoli fate |
| ChIP-seq | Transcription factor binding sites | Map SOX9, GATA4 binding during commitment |
| Immunofluorescence | Protein localization and expression | Validate Sertoli markers (SOX9, AMH) |
| Flow cytometry | Cell surface marker expression | Isolate Sertoli cells for downstream analysis |
| Organ culture | Gonadal development ex vivo | Test effects of drugs or gene manipulations |
Single-cell Transcriptomics
Single-cell RNA sequencing (scRNA-seq) enables profiling of gene expression heterogeneity during Sertoli cell fate commitment. Studies in human and chicken gonads have identified distinct somatic cell lineages and transitional states. This method reveals novel markers and regulatory networks.
Chromatin Accessibility Profiling
Assay for Transposase-Accessible Chromatin with sequencing (ATAC-seq) measures open chromatin regions, identifying enhancers and promoters active during Sertoli cell fate commitment. Single-nucleus ATAC-seq has been applied to chicken gonads, revealing conserved regulatory elements.
CRISPR Screens
Pooled CRISPR knockout screens can systematically identify genes required for Sertoli cell fate commitment. Using reporter cell lines or primary gonadal cells, candidate regulators can be validated in high-throughput.
Lineage Tracing and Imaging
Genetic lineage tracing in mice, using Cre-lox systems, allows visualization of Sertoli cell progenitors and their descendants. Confocal imaging of testis cords provides spatial context for fate commitment.
How CRISPR Can Be Used to Study GO:0060010 Sertoli cell fate commitment
Knockout
CRISPR-Cas9 knockout of candidate genes (e.g., Sry, Sox9) in gonadal somatic cells or model organisms can ablate Sertoli cell fate commitment, revealing essential regulators. Conditional knockout in mice allows temporal control.
Point Mutation
Introducing patient-specific point mutations (e.g., in SOX9 or NR5A1) via CRISPR homology-directed repair (HDR) creates isogenic models to study DSD mechanisms and genotype-phenotype correlations.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags at endogenous loci enables lineage tracing, cell sorting, and biochemical analysis of Sertoli cell fate regulators.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can ectopically express candidate genes (e.g., Sox9) to test sufficiency for Sertoli cell fate commitment in vitro or in vivo.
How EDITGENE Supports Sertoli cell fate commitment Research
Researchers studying Sertoli cell fate commitment-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR-based services to accelerate such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for Sertoli cell fate commitment research.
Frequently Asked Questions About Sertoli cell fate commitment
What is Sertoli cell fate commitment?
Sertoli cell fate commitment (GO:0060010) is the developmental process by which bipotential gonadal somatic cells acquire and stabilize the Sertoli cell identity, essential for testis formation.
What genes are involved in Sertoli cell fate commitment?
Key genes include SRY, SOX9, GATA4, WT1, NR5A1, DMRT1, and AMH, which form a regulatory network driving Sertoli cell differentiation.
What is the role of SRY in Sertoli cell fate commitment?
SRY is the Y-linked trigger that initiates Sertoli cell fate commitment by upregulating SOX9 in XY gonadal somatic cells.
How is Sertoli cell fate commitment regulated?
It is regulated by transcription factor networks, signaling pathways (e.g., FGF9), and epigenetic modifiers that stabilize SOX9 expression and chromatin accessibility.
What diseases are associated with defects in Sertoli cell fate commitment?
Disorders of sex development (DSD), gonadal dysgenesis, and infertility are linked to mutations in genes controlling this process.
What research methods are used to study Sertoli cell fate commitment?
Methods include single-cell RNA-seq, ATAC-seq, CRISPR screens, lineage tracing, and immunofluorescence.
Can CRISPR be used to model Sertoli cell fate commitment disorders?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study gene function and disease mechanisms.
What is the difference between Sertoli cell fate commitment and Sertoli cell differentiation?
Fate commitment refers to the initial acquisition and stabilization of Sertoli identity, while differentiation encompasses subsequent functional maturation.
Which species are used to study Sertoli cell fate commitment?
Mouse models are most common, but human, chicken, and other vertebrate models provide comparative insights.
How does environmental exposure affect Sertoli cell fate commitment?
Endocrine-disrupting chemicals like phthalates can disrupt fetal Sertoli cell development, leading to testicular dysgenesis.
Conclusion
Sertoli cell fate commitment (GO:0060010) is a cornerstone of male sex determination and testis development, governed by a sophisticated network of transcription factors, signaling pathways, and epigenetic regulators. Disruptions in this process lead to DSD, gonadal dysgenesis, and infertility, making it a critical area of biomedical research. Advances in single-cell omics and CRISPR technologies continue to unravel the molecular details of this fate decision, offering potential for diagnostic and therapeutic innovations. EDITGENE's suite of CRISPR services supports researchers in dissecting the genetic and epigenetic basis of Sertoli cell fate commitment.
References
- 1. O'Donnell L et al.. 2022. Sertoli cells as key drivers of testis function.. Semin Cell Dev Biol 121:2-9 PMID: 34229950
- 2. Lin YT et al.. 2015. Cell fate commitment during mammalian sex determination.. Curr Opin Genet Dev 32:144-52 PMID: 25841206
- 3. Lardenois A et al.. 2026. Single-cell exploration of gonadal somatic cell lineage specification during human sex determination.. Dev Cell 61(2):400-415.e6 PMID: 41072414
- 4. Nef S et al.. 2019. Characterizing the bipotential mammalian gonad.. Curr Top Dev Biol 134:167-194 PMID: 30999975
- 5. Li J et al.. 2025. Single-nucleus transcriptional and chromatin accessible profiles reveal critical cell types and molecular architecture underlying chicken sex determination.. J Adv Res 70:29-43 PMID: 38734369
- 6. Dupont S et al.. 2021. The Chromatin State during Gonadal Sex Determination.. Sex Dev 15(5-6):308-316 PMID: 34753132
- 7. Stévant I et al.. 2019. Genetic Control of Gonadal Sex Determination and Development.. Trends Genet 35(5):346-358 PMID: 30902461
- 8. Li H et al.. 2021. REPRODUCTIVE TOXICOLOGY: Environmental exposures, fetal testis development and function: phthalates and beyond.. Reproduction 162(5):F147-F167 PMID: 34314370
